Androgen receptor expression in endometrial carcinoma and its correlation with clinicopathologic features

Atif Ali Hashmi, Zubaida Fida Hussain, Amna Qadri, Muhammad Irfan, Sahar Ramzan, Naveen Faridi, Amir Khan, Muhammad Muzzammil Edhi

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)


Objectives: Recent evidence suggests a role of androgen receptor expression as a prognostic and therapeutic biomarker in endometrial carcinoma, therefore in the present study we aimed to evaluate the frequency of androgen expression in different subtypes of endometrial carcinoma and its association with clinic-pathologic features. Results: 18/89 (20.2%) cases of endometrial carcinoma showed positive androgen receptor expression. On the other hand, low, moderate and high androgen receptor expression was noted in 7/89 (7.9%), 10/89 (11.2%) and 1/89 (1.1%) cases respectively. 15/77 (19.48%) of endometrioid cancers and 3/7 (42.28%) cases of serous carcinoma showed androgen receptor expression; while none of the cases of clear cell or carcinosarcoma revealed androgen receptor expression. No significant association of androgen receptor expression with various clinicopathologic features of endometrial carcinoma was noted. We found that a significant subset of endometrial cancers express androgen receptor especially a serous cancers; therefore we suggest that androgen receptor expression testing should be done in endometrial carcinoma.

Original languageEnglish
Article number289
JournalBMC Research Notes
Issue number1
Publication statusPublished - 10 May 2018
Externally publishedYes


  • Androgen receptor
  • Carcinosarcoma
  • Endometrial cancer
  • Endometrioid carcinoma
  • Serous carcinoma


Dive into the research topics of 'Androgen receptor expression in endometrial carcinoma and its correlation with clinicopathologic features'. Together they form a unique fingerprint.

Cite this